Genetic/Familial High Risk Assessment: Breast and Ovarian Cancer

Main|Search|PHGKB




Last Posted: Oct 06, 2017

---

• Genetic/Familial High Risk Assessment: Breast and Ovarian Cancer  
  NCCN Guidelines, October 2017
• [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].  
  Arai Masami et al. Gan to kagaku ryoho. Cancer & chemotherapy 2014 Nov 41(11) 1333-9
• [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].  
  Arai Masami et al. Gan to kagaku ryoho. Cancer & chemotherapy 2012 Apr 39(4) 525-31
• Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.  
  Derks-Smeets I A P et al. Human reproduction (Oxford, England) 2014 May 29(5) 1103-12
• Development of a brochure for increasing awareness of inherited breast cancer in black women.  
  Vadaparampil Susan T et al. Genetic testing and molecular biomarkers 15(1-2) 59-67
• Development of a culturally tailored genetic counseling booklet about hereditary breast and ovarian cancer for Black women.  
  Permuth-Wey Jennifer et al. American journal of medical genetics. Part A 2010 Apr 152A(4) 836-45
• Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.  
  Katapodi Maria C et al. Oncology nursing forum 2011 Sep 38(5) 572-81
• Final report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology, on a fact-finding questionnaire on the status of treatment of hereditary breast and ovarian cancer syndrome in Japan.  
  Satoh Toyomi et al. The journal of obstetrics and gynaecology research 2017 Sep 43(9) 1377-1380
• Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites.  
  Digennaro M et al. Hereditary cancer in clinical practice 2017 157
• Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.  
  Meaney-Delman Dana et al. Obstetrics and gynecology clinics of North America 2013 Sep 40(3) 475-512
• Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.  
  Bando Hiroko et al. Breast cancer (Tokyo, Japan) 2014 Nov 21(6) 656-63
• Living With Genetic Vulnerability: a Life Course Perspective.  
  Hamilton Rebekah J et al. Journal of genetic counseling 2016 Feb 25(1) 49-61
• Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.  
  Jeffers Lisa et al. European journal of oncology nursing : the official journal of European Oncology Nursing Society 2014 Aug 18(4) 411-8
• Medical mistrust influences black women's level of engagement in BRCA 1/2 genetic counseling and testing.  
  Sheppard Vanessa B et al. Journal of the National Medical Association 2013 105(1) 17-22
• Preferences for hereditary breast and ovarian cancer information among Mexican, Cuban and Puerto Rican women at risk.  
  Quinn Gwendolyn P et al. Public health genomics 2011 14(4-5) 248-58
• Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.  
  Katapodi Maria C et al. Nursing research 60(6) 368-77

more